The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / W••••• L••••••

A••••••• Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition of W•••••

Add-on acquisitionannouncedadd-onannouncement date unknownFact
What happened
Target
W••••• L••••••
Platform
A•••••••add-on basis: A••••••• is held by W••• P•••• P••••••• (holding evidence as written before reparse (A••••••• Specialties is held by W••• P•••• P••••••• (holding evidence http://www.wppartners.com/companies/)))
Control
Control
Share acquired
unknown
Industry
industrials / chemical, manufactur
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • A•••••••Platformconfirmed
    “A••••••• is held by W••• P•••• P••••••• (holding evidence as written before reparse (A••••••• Specialties is held by W••• P•••• P••••••• (holding evidence http://www.wppartners.com/companies/)))”
  • W••• P•••• P•••••••Sponsorattribution unknown
    “A••••••• is held by W••• P•••• P••••••• (holding evidence as written before reparse (A••••••• Specialties is held by W••• P•••• P••••••• (holding evidence http://www.wppartners.com/companies/)))”
Side not stated
  • M••• H•••Managementconfirmed
    ““W••••• is an exciting addition to A••••••• and aligns with our commitment to serving the pharmaceutical space,” said M••• H•••, Chief Executive Officer of A•••••••.”
  • D•••• B•••Managementconfirmed
    ““We are proud of W•••••’s reputation for quality and customer service, and its emergence as a leading European, independent fine chemical manufacturer,” said D•••• B•••, General Manager of W•••••.”
  • W••••• L••••••Targetconfirmed
    “A••••••• Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition of W•••••”
Evidence
“A••••••• Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition of W•••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
A••••••• Expands Fine Chemicals Production Capabilities for Life Sciences with Acquisition | Private Equity Intelligence | DFX